£260k
+431%vs Dec 2024Active11032656Private limited companyLondon
TEYSHA TECHNOLOGIES LIMITED
Significant control: Matthew Stone (25–50%)
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
Watch this company
Get an email when Companies House records a change for Teysha Technologies Limited: status, filings, accounts, officers or owners. Free.
Not live yet: alerts start by 15 December 2026. We store your email and this company number only, for these alerts. If alerts don’t launch, we tell you and delete your address. Privacy
Coming soon · product and service lists
What does Teysha Technologies Limited sell?
Registered activity: Research and experimental development on biotechnology (SIC 72110). We’re building product and service lists for UK companies. Get this one when it’s ready.
One email, only about this. If we don’t launch within 60 days we’ll tell you. Privacy
01
Summary
TEYSHA TECHNOLOGIES LIMITED is an active private limited company (company number 11032656) incorporated on 26 October 2017, registered in London. Its registered activity is research and experimental development on biotechnology (SIC 72110). Latest small accounts cover the period ending 31 December 2025, showing net assets of £260k and cash of £38k, with 7 employees on average. Net assets rose 431% on the prior period (£49k). Across the last 3 periods on record the net-asset trend is volatile.
Peer position · net assets
By net assets it sits in the top quarter of 603 comparable companies in London (median £440, upper quartile £92k).
02
Ownership and control
- Mr Matthew Stone
- owns 25–50% of shares
- holds 25–50% of voting rights
- can appoint or remove directors
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
03
Key dates
- Incorporated
- 26 October 20178 yrs ago
- Next accounts due
- 30 September 2027in 340 days
- Confirmation statement due
- 9 November 2026in 15 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
04
Activity
- SIC 72110
- Research and experimental development on biotechnology
- Accounts type
- Total Exemption Full
- Size band
- MicroCompanies Act thresholds
05
Financials
£38k
Not reported the period beforeNot reported
7
+17%vs Dec 2024| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 31 December 2025 | £260k | £38k | — | — | — | −£1.45m | 7 |
| 31 December 2024 | £49k | — | — | — | — | — | 6 |
| 31 December 2023 | £98k | — | — | — | — | — | 6 |
Cash per employee£5,386Cash ÷ average employees
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing.
06
Filing and accounts signals
- Net assets above zeroNet assets £260,496 at 31 December 2025
- Net assets up 10% or more on the prior period+430.7% vs prior period
- Three or more accounting periods on record3 periods on record
- Incorporated five or more years agoIncorporated 26 October 2017
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
07
Timeline
- Next accounts duein 340 days
- Confirmation statement duein 15 days
- Accounts period endNet assets £260k · small accounts
- Accounts period endNet assets £49k · small accounts
- Accounts period endNet assets £98k · small accounts
- Incorporated
08
Similar companies in London
- NEXTGEN NANO LIMITEDLondon · inc. Oct 2017
- MEREO BIOPHARMA 4 LIMITEDLondon · inc. Oct 2017
- MINDVISIONLABS LIMITEDLondon · inc. Oct 2017
- NANO-NOSE LIMITEDLondon · inc. Oct 2017
- GROW GROUP LIMITEDLondon · inc. Nov 2017
- REMEDY LABS RESEARCH GROUP LTDLondon · inc. Nov 2017
All companies incorporated on 26 October 2017 · in Oct 2017.
09
Reminders for TEYSHA TECHNOLOGIES LIMITED
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.